Clinical Psychiatry News

Clinical Psychiatry News is a monthly medical and psychiatry tabloid published since 1973 by the International Medical News Group. Subjects for Clinical Psychiatry News include psychology and psychiatry. The executive editor is Denise Fulton, and Gina Henderson is a senior editor.

Articles from Vol. 30, No. 4, April

A Beautiful Mind. (Reel Life)
This year there were four Oscar nominations for portrayals of mental illness: Russell Crowe's schizophrenia, Judi Dench's Alzheimer's, Sean Penn's mental retardation, and Ben Kingsley's psychopath. Do we overestimate the accomplishments of actors...
Acetylcholinesterase Inhibitors Improve Behavior. (Increasing Evidence)
ORLANDO, FLA. -- Increasing evidence suggests that cholinesterase inhibitors can produce significant, long-term improvements in behavioral symptoms associated with Alzheimer's disease, Dr. Mustafa M. Husain said at the annual meeting of the American...
Active Ingredient in Citalopram May Stand Alone. (Lower Dose, Fewer Side Effects)
NEW YORK -- Escitalopram, one of the two mirror-image compounds that make up the antidepressant citalopram, appears to have advantages over that drug in side effect profile and possibly efficacy as well, Dr. David L. Ginsberg said at a conference on...
ADHD Often Manifests as Inattentive Type in Girls. (Less Likely to Be Treated)
HONOLULU -- Girls with attention-deficit hyperactivity disorder were more likely to have the inattentive type and were less likely to receive treatment than were boys with the disorder in a secondary analysis of data on 522 children, Dr. Joseph Biederman...
APA President-Elect Vows to Bolster Membership. (Low Voter Turnout)
The American Psychiatric Association's new president-elect, Dr. Marcia K. Goin, said that outreach, both to the public and to psychiatrists, will be the overarching theme of her agenda. Dr. Goin, current APA vice president and clinical professor...
Apolipoprotein E May Modulate Cortisol Production. (Alzheimer's Disease Risk)
ORLANDO, FLA. -- Apolipoprotein E genotype, the most powerful genetic risk factor yet identified for Alzheimer's disease, accounts for 50% of heritability But how the choleresterol protein transporter influences pathogenesis remains unknown. Data...
Apolipoprotein [Epsilon]4 Confers General Brain Vulnerability: Consequences Include Faster Brain Aging. (Sensitivity to Drug Effects)
ORLANDO, FLA. -- The apolipoprotein E genotype is well recognized as a significant risk factor for Alzheimer's disease, but its importance may be far broader, according to data presented at the annual meeting of the American Association for Geriatric...
Approach Developmentally Disabled with Extra Care. (Take Care in Prescribing)
NEW YORK -- Diagnosis and treatment of psychiatric disorders in young people with developmental disabilities require special care, Dr. John Pomeroy said at a psychopharmacology update sponsored by the American Academy of Child and Adolescent Psychiatry....
Caffeine Interacts with Some Psychoactive Meds. (Be Alert for Adverse Reactions)
TUCSON, ARIZ. -- Caffeine interacts with a number of psychoactive medications, and physicians must be alert to potentially serious consequences, Marilyn R. Semenchuk, Pharm.D., said at a psychopharmacology conference sponsored by the University of...
Cannabis-Induced Cognitive Deficits Fade by Day 28. (Abstinence)
A marked impairment in the ability of heavy smokers of cannabis to memorize word lists during their first 7 days of abstinence was no longer apparent by day 28, reported Dr. Harrison G. Pope Jr. of Harvard Medical School, Boston, and his associates....
Consider 'Hands-On' Approach in PTSD Therapy. (Symbolically Communicates Nurturing)
NEW YORK -- By dispensing pain medication, examining scars, and taking pulse and blood-pressure readings, a psychiatrist can communicate powerful symbolic messages to the patient with posttraumatic stress disorder, said Dr. Sharon Sageman at the annual...
Court Faults Insurance Carriers That Discriminate. (Definition of Mental Illness Ambiguous)
In a precedent-setting decision, the U.S. District Court for the District of Columbia has erased the distinctions that have long separated physical and mental illnesses in insurance policy coverage. In Fitts v. Federal National Mortgage Association,...
Donepezil Cuts Alzheimer's Health Care Costs. (Long-Term Treatment)
ORLANDO, FLA. -- Sustained treatment with the acetyicholinesterase inhibitor donepezil significantly reduced health care costs for patients with Alzheimer's disease in a Medicare-managed care organization plan, Jerrold W Hill, Ph.D., said at the annual...
First Atypical Comparison May Individualize Care. (Chronic Schizophrenia)
Clozapine, olanzapine, and risperidone all significantly reduced symptoms in patients with chronic schizophrenia or schizoaffective disorder, Dr. Jan Volavka and his associates said. This first known comparison study of these atypical antipsychotics--and...
Focusing Patients' Attention on Pain May Actually Worsen It. (A New Pain Paradigm)
PITTSBURGH -- Encouraging patients to focus too much attention on their sensory perceptions of pain can effect physiologic changes in neural signaling that actually increase levels of discomfort, Dr. Lonnie K. Zeltzer said at a meeting on managing...
Forensic Training Promotes Informed Consent. (Age, Experience Not a Factor)
BOSTON -- Psychiatrists with forensic training are more likely to follow correct procedures in securing patients' informed consent for psychotherapy or pharmacotherapy, Dr. Matthew Kleban said at the annual meeting of the American Academy of Psychiatry...
Generic Fluoxetine May Offer Lower Bioequivalence. (Anecdotal Reports)
TUCSON, ARIZ. -- Leaders in the field of psychopharmacology are fielding widespread anecdotal reports that generic versions of fluoxetine may have diminished bioequivalence compared with brand name Prozac, said Dr. Alan J. Gelenberg, head of the department...
Gestures Reveal What the Lips Conceal. (Literature on Mendacity)
On August 17, 1998, Dr. Alan Hirsch was working out at his gym. He could see President Bill Clinton testifying before a federal grand jury on a nearby television but he didn't have a set of headphones to listen in. He didn't need to. "I saw him...
Many Parents Use Alternative Therapies for ADHD. (Few Tell Their Physicians)
SAN DIEGO -- Surveys indicate that many parents are trying complementary and alternative therapies for their children with attention-deficit hyperactivity disorder, but few tell their physicians about it, Dr. Kathi J. Kemper said at a meeting sponsored...
Methamphetamines Kill Dopamine Transporters. (Loss May Be Partially Reversible)
Loss of dopamine transporters has been documented in methamphetamine abusers and may be the common thread underlying many drug addictions, reported Dr. Nora D. Volkow of Brookhaven National Laboratory in Upton, N.Y, and her associates. The neurotransmitter...
Monitor Kidney Function with Long-Term Lithium. (Most Patients Do Fine)
NEW YORK -- Clinical and medicolegal considerations make monitoring kidney function essential with lithium treatment, and, when possible, treatment should involve a collaborative relationship with a nephrologist, Dr. James W. Jefferson said at a conference...
No Age Difference in Speed of Antidepressant Response. (Early Response Predicts Outcome)
ORLANDO, FLA. -- Contrary to well-established belief, elderly depressed patients do not respond to pharmacotherapy more slowly than younger patients, and thus do not necessarily require longer medication trials, Harold A. Sackeim, Ph.D., said in an...
OxyContin Abusers Tend to Be Addicts First. (282 Deaths from Overdose in 7-Year Period)
Patients who become addicted to oxycodone hydrochloride controlled-release (OxyContin, Purdue Pharma) generally are those who struggle with addiction, not those who have problems with pain, Wesley Clark, director of the Center for Substance Abuse Treatment...
Practical Psychopharmacology: Psychosocial Approaches Complement Medication in Schizophrenia Treatment. (Psychopharmacology)
Few would question that medication is the bedrock of schizophrenia treatment. The evolution of antipsychotics is the major theme of recent research, and the appropriate use of these agents is the primary concern of clinicians. But drugs are not...
Protracted Withdrawal Is a Real Syndrome. (Real Treatment Implications)
AMELIA ISLAND, FLA. -- Protracted withdrawal from alcohol, hypnotics, psychostimulants, and other agents is a real syndrome with real treatment implications, Dr. David Cohn reported in a presentation at the annual meeting of the American Academy of...
Psychologist Heads Yale Child Center. (Recruitment Concerns Voiced)
A psychologist is the new director of the prestigious Yale Child Study Center in New Haven, a move that has sparked strong reactions across the psychiatric academic community. Alan E. Kazdin, Ph.D., director of the Yale Child Conduct Clinic and...
Psychologists Gain Right to Prescribe in New Mexico: 'New Mexico Should Be Seen as a Sad Anomaly,' Not the Start of a Perverse Trend. (Law Takes Effect July 1, 2002)
Psychologists scored a big win over psychiatrists last month when they gained the right to prescribe psychotropic medications in New Mexico. House bill 170, which passed with little opposition in the state legislature, was signed into law by Gov....
Psychologists Prescribing
In taking the unprecedented step of approving a psychologist-prescribing bill, the New Mexico legislature and Republican Gov. Gary E. Johnson have ignored all the reasons presented to them that explain why this action represents a danger to the quality...
Quality Housing Is Critical for Treating Homeless with Dual Diagnoses. (Individualized Care Is Best)
TUCSON, ARIZ. -- The most effective programs for treating homeless patients with dual diagnoses ensure that patients have access to quality housing--either in group homes or independent apartments, Dr. Stephen Goldfinger said at a meeting on mental...
SSRIs Are Associated with Mild Cognitive Impairment. (Watch Geriatric Patients Closely)
NEW YORK -- Selective serotonin reuptake inhibitors may produce cognitive impairment that is mild but sufficient to have a negative impact on patients' daily lives, Patricia M. Furlan, Ph.D., said at a conference on psychopharmacology sponsored by...
SSRIs Can Reduce Poststroke Mood Disorders. (Randomized, Controlled Study: 116 Patients)
SAN ANTONIO -- The depression, emotionalism, and anxiety that frequently appear following a stroke can often be helped by treatment with a selective serotonin reuptake inhibitor. Results from a new randomized, controlled study of 116 poststroke...
Still at Large. (Opinion)
According to the American Academy of Child and Adolescent Psychiatry, at least 80,000 cases of child sexual abuse are reported annually, and many more go unreported. Yet the National Child Abuse and Neglect Data System estimates that cases of substantiated...
Target Symptoms, Not Diagnosis, Should Guide PDD Drug Therapy. (Neurobiologic Rationale)
NEW YORK -- The pharmacotherapy of children and adolescents with pervasive developmental disorder is best guided by target symptoms, rather than diagnosis, Dr. Robert Hendren said at a psychopharmacology update sponsored by the American Academy of...
Therapy Alone Can Work in Recurrent Depression. (in Elderly)
ORLANDO, FLA. -- Interpersonal psychotherapy combined with medication has been shown to reduce depression recurrence among elderly patients at high risk, but this multimodal approach may not be necessary for all, Dr. Charles F. Reynolds III said at...
Treating Depression Doesn't Improve MI Survival, Trial Finds. (CBT Found Ineffective)
ANAHEIM, CALIF. -- The young field of behavioral medicine has taken a pratfall in its first large national trial, in which psychotherapy for depression and social isolation failed to improve acute MI survival. Major depression and/or social isolation...
Two Modalities Rival Prolonged Exposure for PTSD. (171 Sexual Assault Patients)
PHILADELPHIA -- Two treatments--cognitive processing therapy, and eye movement desensitization and reprocessing--appear as effective for posttraumatic stress disorder as prolonged exposure, which has been the treatment of choice. Both treatments...
Vascular Dementia Appears to Respond to Cholinergic Drugs. (Does Diagnosis Matter?)
ORLANDO, FLA. -- Diagnostic precision may often be beside the point in treating dementia: Two of the most common causes, Alzheimer's disease and vascular dementia, appear to respond comparably to the same medications, Dr. Gary Small said at the annual...
VA to Enhance Opioid Counseling, Long-Term Maintenance. (Take-Home Privileges)
AMELIA ISLAND, FLA. -- Optimizing treatment outcome through enhanced services and long-term maintenance is the objective of a new Veterans Administration program designed to assist opioid-agonist clinics, Hildi Hagedorn, Ph.D., reported at the annual...
Virtual Reality Makes Exposure Therapy More Palatable, Effective. (for Specific Phobia)
PHILADELPHIA -- Virtual-reality technology can provide exposure therapy for fears and phobias in a form that eliminates much of the difficulty that can keep patients out of conventional treatment, Dr. Azucena Garcia-Palacios said at the annual meeting...
Search by... Author
Show... All Results Primary Sources Peer-reviewed

Oops!

An unknown error has occurred. Please click the button below to reload the page. If the problem persists, please try again in a little while.